Literature DB >> 4043964

N-Acetylneuraminic acid storage disease.

J Baumkötter, M Cantz, K Mendla, W Baumann, H Friebolin, J Gehler, J Spranger.   

Abstract

Increased amounts of free sialic acid were found in body fluids, leukocytes, cultured fibroblasts, and liver tissue of a four-year-old boy with mental retardation, ataxia, and clinical and radiologic findings of a mild mucopolysaccharidosis. A diagnosis of Salla disease was made though in contrast to earlier reports, recurrent upper respiratory infections and hepatosplenomegaly were present already in infancy, and skeletal abnormalities of dysostosis multiplex were found in early childhood. Free sialic acid in the urine was identified as N-acetylneuraminic acid by 1H-NMR spectroscopy. Sialidase activities were normal. Increased amounts of bound sialic acid were found in liver and cultured fibroblasts and were attributed to an intracellular inhibition of sialyloligosaccharide-degrading neuraminidase by excessive amounts of free neuraminic acid. The molecular basis of N-acetylneuraminic acid storage disease is unknown but may be related to a defective transport mechanism preventing neuraminic acid from leaving the lysosomal compartment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043964     DOI: 10.1007/bf00283373

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

Review 1.  Sialidosis: a review of human neuraminidase deficiency.

Authors:  J A Lowden; J S O'Brien
Journal:  Am J Hum Genet       Date:  1979-01       Impact factor: 11.025

2.  [Sialuria: an original metabolic disorder].

Authors:  G Fontaine; G Biserte; J Montreuil; A Dupont; J P Farriaux
Journal:  Helv Paediatr Acta       Date:  1968

3.  Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism.

Authors:  M Renlund; P Aula; K O Raivio; S Autio; K Sainio; J Rapola; S L Koskela
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

4.  Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation.

Authors:  L Skoza; S Mohos
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

5.  Familial lysosomal storage disease with generalized vacuolization and sialic aciduria. Sporadic Salla disease.

Authors:  K Wolburg-Buchholz; W Schlote; J Baumkötter; M Cantz; H Holder; K Harzer
Journal:  Neuropediatrics       Date:  1985-05       Impact factor: 1.947

6.  N-acetylneuraminic acid and sialoglycoconjugate metabolism in fibroblasts from a patient with generalized N-acetylneuraminic acid storage disease.

Authors:  L W Hancock; A L Horwitz; G Dawson
Journal:  Biochim Biophys Acta       Date:  1983-10-04

7.  Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds.

Authors:  J Baumkötter; M Cantz
Journal:  Biochim Biophys Acta       Date:  1983-12-13

8.  Sialic acid storage disease with sialuria: clinical and biochemical features in the severe infantile type.

Authors:  R E Stevenson; M Lubinsky; H A Taylor; D A Wenger; R J Schroer; P M Olmstead
Journal:  Pediatrics       Date:  1983-10       Impact factor: 7.124

9.  Generalized N-acetylneuraminic acid storage disease: quantitation and identification of the monosaccharide accumulating in brain and other tissues.

Authors:  L W Hancock; M M Thaler; A L Horwitz; G Dawson
Journal:  J Neurochem       Date:  1982-03       Impact factor: 5.372

10.  Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts.

Authors:  M Hollemans; R O Elferink; P G De Groot; A Strijland; J M Tager
Journal:  Biochim Biophys Acta       Date:  1981-04-22
View more
  14 in total

1.  Storage material from urine and tissues in the nephropathic phenotype of infantile sialic acid storage disease.

Authors:  E Paschke; W Gruber; E Ring; W Sperl
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Free N-acetylneuraminic acid (NANA) storage disorders: evidence for defective NANA transport across the lysosomal membrane.

Authors:  G M Mancini; F W Verheijen; H Galjaard
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

3.  Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.

Authors:  G M Mancini; C E Beerens; P P Aula; F W Verheijen
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Infantile Sialic Acid Storage Disease: Two Unrelated Inuit Cases Homozygous for a Common Novel SLC17A5 Mutation.

Authors:  Matthew A Lines; C Anthony Rupar; Jack W Rip; Berivan Baskin; Peter N Ray; Robert A Hegele; David Grynspan; Jean Michaud; Michael T Geraghty
Journal:  JIMD Rep       Date:  2013-07-31

Review 5.  Disorders of glycoprotein degradation.

Authors:  M Cantz; B Ulrich-Bott
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Nephrosis in two siblings with infantile sialic acid storage disease.

Authors:  W Sperl; W Gruber; J Quatacker; L Monnens; W Thoenes; F M Fink; E Paschke
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

7.  Free sialic acid storage disease. A new Italian case.

Authors:  A Fois; P Balestri; M A Farnetani; G M Mancini; P Borgogni; M A Margollicci; M Molinelli; C Alessandrini; R Gerli
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 8.  Neuropathology of Salla disease.

Authors:  H Autio-Harmainen; A Oldfors; P Sourander; M Renlund; K Dammert; S Similä
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 9.  Prenatal diagnosis of inborn errors of metabolism with renal manifestations.

Authors:  E Harms
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease.

Authors:  K Mendla; J Baumkötter; C Rosenau; B Ulrich-Bott; M Cantz
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.